Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients

Assunta Bianco, Pier-Valerio Mari, Anna Rita Larici, Matteo Lucchini, Viviana Nociti, Francesco Antonio Losavio, Chiara De Fino, Giuseppe Cicchetti, Daniele Coraci, Luca Richeldi, Massimiliano Mirabella

Risultato della ricerca: Contributo in rivistaEditoriale in rivista / quotidiano

7 Citazioni (Scopus)


Background: Respiratory alemtuzumab-related adverse events are clinically heterogeneous and include respiratory infections, infusion-related dyspnea, hypoxia and secondary autoimmune disorders. Case report: Here we report three cases of drug-induced lung disease following treatment with alemtuzumab in multiple sclerosis patients. First case was diagnosed as a non-specified intestitial pneumonitis associated with organizing pneumonia with subacute onset, second case was an acute respiratory distress syndrome with onset during second cycle, third case was a diffuse acute alveolar hemorrhage during first cycle infusion. All patients developed acute respiratory failure, reversible after steroid therapy. Conclusions: Clinicians should be aware to early recognize acute and subacute respiratory adverse events for a promptly management. In these patients re-treatment is challenging.
Lingua originaleEnglish
pagine (da-a)1-3
Numero di pagine3
RivistaMultiple Sclerosis and Related Disorders
Stato di pubblicazionePubblicato - 2020


  • Acute respiratory distress syndrome
  • Diffuse alveolar haemorrhage
  • Interstitial pneumonitis
  • Personalized medicine
  • Pulmonary toxicity


Entra nei temi di ricerca di 'Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients'. Insieme formano una fingerprint unica.

Cita questo